Sign In
Upcoming Event
Free Newsletter
CorneaGen acquires Baltimore’s KeraLink International
CorneaGen acquires Baltimore’s KeraLink International
Listen to this articleSeattle-based CorneaGen, the largest provider of corneal tissue for transplant in the world, announced Monday it will acquire the domestic eye bank operations and related assets of KeraLink International, a Baltimore-based nonprofit offering corneal transplantation services, supplies and grafts for transplant.
Terms of the deal, which becomes effective March 1, were not disclosed. KeraLink will continue to operate as an independent, nonprofit, with its sights set on making vision-restoring treatments for people with corneal blindness possible anywhere in the world. KeraLink’s goal is to provide better options to more than 10 million people who currently live without sight, because corneal transplant tissue is not available, not affordable or surgeons’ skills are not sufficient.
CorneaGen will absorb all of KeraLink’s operating locations, enter into affiliate agreements with KeraLink’s affiliates in Albuquerque, New Mexico and San Antonio, and employ most, if not all, of KeraLink’s operations personnel at their current locations. CorneaGen also will support KeraLink’s efforts by providing access to tissue, facilities and personnel.
